These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32610794)

  • 21. Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward.
    Baltussen R; Marsh K; Thokala P; Diaby V; Castro H; Cleemput I; Garau M; Iskrov G; Olyaeemanesh A; Mirelman A; Mobinizadeh M; Morton A; Tringali M; van Til J; Valentim J; Wagner M; Youngkong S; Zah V; Toll A; Jansen M; Bijlmakers L; Oortwijn W; Broekhuizen H
    Value Health; 2019 Nov; 22(11):1283-1288. PubMed ID: 31708065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HTA - Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
    Culyer AJ
    Int J Health Policy Manag; 2016 Aug; 5(8):501-505. PubMed ID: 27694664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.
    Howard S; Scott IA; Ju H; McQueen L; Scuffham PA
    Aust Health Rev; 2019 Oct; 43(5):591-599. PubMed ID: 30205873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patients and public are important stakeholders in health technology assessment but the level of involvement is low - a call to action.
    Wale JL; Thomas S; Hamerlijnck D; Hollander R
    Res Involv Engagem; 2021 Jan; 7(1):1. PubMed ID: 33402216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards Integrated Health Technology Assessment for Improving Decision Making in Selected Countries.
    Oortwijn W; Determann D; Schiffers K; Tan SS; van der Tuin J
    Value Health; 2017 Sep; 20(8):1121-1130. PubMed ID: 28964444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing evidence-informed deliberative processes in health technology assessment: a low income country perspective.
    Kapiriri L; Baltussen R; Oortwijn W
    Int J Technol Assess Health Care; 2020; 36(1):29-33. PubMed ID: 31944173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
    Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Santos VC; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e37. PubMed ID: 35656641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expanded HTA, Legitimacy and Independence Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
    Syrett K
    Int J Health Policy Manag; 2016 Sep; 5(9):565-567. PubMed ID: 27694685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force.
    Oortwijn W; Husereau D; Abelson J; Barasa E; Bayani DD; Canuto Santos V; Culyer A; Facey K; Grainger D; Kieslich K; Ollendorf D; Pichon-Riviere A; Sandman L; Strammiello V; Teerawattananon Y
    Value Health; 2022 Jun; 25(6):869-886. PubMed ID: 35667778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes.
    Street J; Stafinski T; Lopes E; Menon D
    Int J Technol Assess Health Care; 2020 Apr; 36(2):87-95. PubMed ID: 32151290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EVALUATION OF PATIENT AND PUBLIC INVOLVEMENT INITIATIVES IN HEALTH TECHNOLOGY ASSESSMENT: A SURVEY OF INTERNATIONAL AGENCIES.
    Weeks L; Polisena J; Scott AM; Holtorf AP; Staniszewska S; Facey K
    Int J Technol Assess Health Care; 2017 Jan; 33(6):715-723. PubMed ID: 29122048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EXPLORING VALUES OF HEALTH TECHNOLOGY ASSESSMENT AGENCIES USING REFLECTIVE MULTICRITERIA AND RARE DISEASE CASE.
    Goetghebeur MM; Wagner M; Samaha D; O'Neil W; Badgley D; Castro-Jaramillo H; Abrishami P; Sarria-Santamera A; Cleemput I; Tringali M
    Int J Technol Assess Health Care; 2017 Jan; 33(4):504-520. PubMed ID: 29019295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond the Black Box Approach to Ethics! Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
    Sandman L; Gustavsson E
    Int J Health Policy Manag; 2016 Apr; 5(6):393-4. PubMed ID: 27285520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HEALTH TECHNOLOGY ASSESSMENT, DELIBERATIVE PROCESS, AND ETHICALLY CONTESTED ISSUES.
    Daniels N; van der Wilt GJ
    Int J Technol Assess Health Care; 2016 Jan; 32(1-2):10-5. PubMed ID: 27472157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "It all depends": conceptualizing public involvement in the context of health technology assessment agencies.
    Gauvin FP; Abelson J; Giacomini M; Eyles J; Lavis JN
    Soc Sci Med; 2010 May; 70(10):1518-26. PubMed ID: 20207061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health technology assessment and priority setting for universal health coverage: a qualitative study of stakeholders' capacity, needs, policy areas of demand and perspectives in Nigeria.
    Uzochukwu BSC; Okeke C; O'Brien N; Ruiz F; Sombie I; Hollingworth S
    Global Health; 2020 Jul; 16(1):58. PubMed ID: 32641066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Need for Global Application of the Accountability for Reasonableness Approach to Support Sustainable Outcomes Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
    Byskov J; Maluka SO; Marchal B; Shayo EH; Bukachi S; Zulu OM; Blas E; Michelo C; Ndawi B; Hurtig AK
    Int J Health Policy Manag; 2017 Feb; 6(2):115-118. PubMed ID: 28812788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modes of coordination for health technology adoption: Health Technology Assessment agencies and Group Procurement Organizations in a polycentric regulatory regime.
    Miller FA; Lehoux P; Rac VE; Bytautas JP; Krahn M; Peacock S
    Soc Sci Med; 2020 Nov; 265():113528. PubMed ID: 33261901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community views and perspectives on public engagement in health technology assessment decision making.
    Wortley S; Tong A; Howard K
    Aust Health Rev; 2017 Mar; 41(1):68-74. PubMed ID: 27050156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PUBLIC AND PATIENT INVOLVEMENT IN HEALTH TECHNOLOGY ASSESSMENT: A FRAMEWORK FOR ACTION.
    Abelson J; Wagner F; DeJean D; Boesveld S; Gauvin FP; Bean S; Axler R; Petersen S; Baidoobonso S; Pron G; Giacomini M; Lavis J
    Int J Technol Assess Health Care; 2016 Jan; 32(4):256-264. PubMed ID: 27670693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.